Intech Biopharm Corporation (TPEX:6461)
22.50
-0.05 (-0.22%)
Apr 2, 2025, 1:19 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 3.10 billion as of April 2, 2025. Its market cap has decreased by -23.56% in one year.
Market Cap
3.10B
Enterprise Value
4.28B
Revenue
39.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.50
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 3.10B, a decrease of -22.49%. That is a compound annual growth rate of -2.35%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PharmaEssentia | 185.17B |
Caliway Biopharmaceuticals | 129.99B |
Bora Pharmaceuticals Co., LTD. | 74.15B |
Lotus Pharmaceutical | 64.08B |
Oneness Biotech | 33.46B |
Lumosa Therapeutics | 31.92B |
Pegavision | 29.52B |
Polaris Group | 28.92B |